KPCB China

The firm was led by partners including Tina Ju, who had a background at Kleiner Perkins in the US. Other partners included Joe Chen (co-founder of Renren) and Amy Wang (per The New York Times, 2011). Decision-making was driven by the local team, though KPCB US partners would occasionally review major allocations.

Yes. KPCB China raised its own fund in 2008, with commitments from Kleiner Perkins and external LPs. The fund structure was ring-fenced, meaning losses or gains were contained within the China vehicle and did not directly affect KPCB's US funds (per The Wall Street Journal, 2011).

By 2018, KPCB China had largely wound down its operations. The firm did not raise a successor fund after its 2008 vehicle expired. Several partners left to form new firms or join other Chinese venture funds. The parent Kleiner Perkins refocused on US and later European investments (per Bloomberg, 2018).

The firm explicitly avoided heavy industrial, real estate, and traditional manufacturing. It also stayed away from regulated sectors like healthcare and financial services, focusing solely on technology and internet-enabled businesses (per public record, 2011).

In its early portfolio companies, KPCB China often led Series A and B rounds, taking board seats. For example, it led a $15M investment in Dianping in 2011 (per TechCrunch, 2011). Later, as the fund matured, it participated in co-investments with Sequoia China and Qiming Venture Partners.

The exact fund size was not publicly disclosed, but reports indicate it was approximately $360 million (per The Wall Street Journal, 2011). This was raised in 2008 and invested over a roughly six-year period.

No. The firm stopped making new investments around 2016 and did not raise a second fund. Its website and LinkedIn presence have been taken down. The brand was effectively retired when Kleiner Perkins rebranded as KPCB in 2019, but the China entity was not revived (per public record).